The lncRNAs in HBV-Related HCCs: Targeting Chromatin Dynamics and Beyond.

HBV HCC LncRNAs biomarkers epigenetic regulation

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
22 Jun 2021
Historique:
received: 19 04 2021
revised: 18 06 2021
accepted: 19 06 2021
entrez: 2 7 2021
pubmed: 3 7 2021
medline: 3 7 2021
Statut: epublish

Résumé

Hepatocellular carcinoma (HCC) represents the fourth leading and fastest rising cause of cancer death (841,000 new cases and 782,000 deaths annually), and hepatitis B (HBV), with 250 million people chronically infected at risk of developing HCC, accounts for >50% of the cases worldwide. Long non-coding RNAs (lncRNAs), untranslated transcripts longer than 200 nucleotides, are implicated in gene regulation at the transcriptional and post-transcriptional levels, exerting their activities both in the nuclear and cytoplasmic compartments. Thanks to high-throughput sequencing techniques, several lncRNAs have been shown to favor the establishment of chronic HBV infection, to change the host transcriptome to establish a pro-carcinogenic environment, and to directly participate in HCC development and progression. In this review, we summarize current knowledge on the role of lncRNAs in HBV infection and HBV-related liver carcinogenesis and discuss the potential of lncRNAs as predictive or diagnostic biomarkers.

Identifiants

pubmed: 34206504
pii: cancers13133115
doi: 10.3390/cancers13133115
pmc: PMC8268133
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : Agence Nationale de Recherches sur le Sida et les Hépatites Virales
ID : ECTZ66014, ECTZ143165, ECTZ160436
Organisme : Agence Nationale de Recherches sur le Sida et les Hépatites Virales
ID : ANR-16-IDEX-0005
Organisme : European Union
ID : EU H2020-667273-HEPCAR, EU H2020-847939-IP-cure-B
Organisme : Agence Nationale de Recherches sur le Sida et les Hépatites Virales
ID : ANR@TRACTION EpiVirHep

Références

Int J Cancer. 2013 Mar 1;132(5):1080-9
pubmed: 22821376
Gut. 2011 Jul;60(7):967-76
pubmed: 21330577
J Biol Chem. 2012 Jul 27;287(31):26302-11
pubmed: 22685290
Mol Cell. 2017 Mar 16;65(6):1056-1067.e5
pubmed: 28306504
Mol Immunol. 2019 Dec;116:18-28
pubmed: 31574452
Front Immunol. 2019 Jan 25;9:3138
pubmed: 30740112
J Orthop Surg Res. 2017 Jul 5;12(1):103
pubmed: 28679390
Oncogene. 2017 Jun 22;36(25):3528-3540
pubmed: 28166203
Oncotarget. 2016 Jul 5;7(27):42422-42430
pubmed: 27285756
Viruses. 2017 Apr 10;9(4):
pubmed: 28394272
Proc Natl Acad Sci U S A. 2009 Jul 14;106(28):11667-72
pubmed: 19571010
J Transl Med. 2016 Nov 28;14(1):328
pubmed: 27894309
Nature. 2016 Mar 17;531(7594):386-9
pubmed: 26983541
Front Genet. 2020 May 06;11:435
pubmed: 32435261
Hepatology. 2014 Mar;59(3):911-23
pubmed: 24114970
World J Gastroenterol. 2020 Aug 7;26(29):4240-4260
pubmed: 32848331
Hepatology. 2011 Nov;54(5):1679-89
pubmed: 21769904
J Cell Physiol. 2020 Dec;235(12):9071-9079
pubmed: 32372477
Biomed Pharmacother. 2018 Sep;105:1133-1140
pubmed: 30021349
J Hepatol. 2016 Feb;64(2):278-291
pubmed: 26409216
iScience. 2018 Apr 27;2:210-220
pubmed: 29888750
Cell Physiol Biochem. 2015;37(2):687-96
pubmed: 26356260
Oncotarget. 2015 Dec 15;6(40):42813-24
pubmed: 26540343
Curr Opin Genet Dev. 2020 Apr;61:53-61
pubmed: 32403014
RNA Biol. 2020 Mar;17(3):381-394
pubmed: 31868085
Oncol Rep. 2020 Jul;44(1):165-173
pubmed: 32627034
Hepatology. 2016 Aug;64(2):671-4
pubmed: 27228461
Nucleic Acids Res. 2010 Sep;38(16):5366-83
pubmed: 20423907
PLoS One. 2014 Oct 09;9(10):e109782
pubmed: 25299640
Oncotarget. 2015 Apr 10;6(10):7899-917
pubmed: 25760077
J Cell Physiol. 2018 Sep;233(9):6508-6517
pubmed: 29574790
Cancer Epidemiol Biomarkers Prev. 2018 Jun;27(6):710-716
pubmed: 29650788
Biomed Pharmacother. 2017 Jun;90:100-108
pubmed: 28343069
PLoS One. 2015 Dec 16;10(12):e0144934
pubmed: 26674525
Hepatology. 2013 May;57(5):1882-92
pubmed: 23239537
Gastroenterology. 2007 Jan;132(1):330-42
pubmed: 17241883
Genome Biol. 2019 Dec 20;20(1):292
pubmed: 31862000
Nat Genet. 2014 Dec;46(12):1267-73
pubmed: 25362482
Cell Death Dis. 2020 Oct 2;11(10):823
pubmed: 33009370
Noncoding RNA. 2020 Jun 03;6(2):
pubmed: 32503170
Oncol Lett. 2017 Aug;14(2):2025-2032
pubmed: 28789433
Carcinogenesis. 2013 Mar;34(3):577-86
pubmed: 23222811
JHEP Rep. 2020 Sep 03;3(1):100177
pubmed: 33294829
J Hepatol. 2020 Nov;73(5):1155-1169
pubmed: 32461121
Nat Struct Mol Biol. 2014 Jul;21(7):633-40
pubmed: 24952594
Hepatology. 2016 Feb;63(2):499-511
pubmed: 25964079
Genome Res. 2012 Sep;22(9):1775-89
pubmed: 22955988
Dis Markers. 2017;2017:7439698
pubmed: 29375177
Medicine (Baltimore). 2016 Aug;95(31):e4436
pubmed: 27495068
Dis Markers. 2015;2015:191029
pubmed: 26136615
Virus Genes. 2018 Aug;54(4):475-483
pubmed: 29789998
Elife. 2015 Dec 19;4:e08890
pubmed: 26687005
Sci Rep. 2016 Mar 24;6:23521
pubmed: 27009634
Biomed Res Int. 2013;2013:136106
pubmed: 23762823
Oncol Lett. 2018 Aug;16(2):1593-1601
pubmed: 30008842
Mol Med Rep. 2019 Aug;20(2):1121-1130
pubmed: 31173205
RNA. 2017 Jul;23(7):1080-1087
pubmed: 28386015
Biochemistry. 2013 Dec 31;52(52):9519-27
pubmed: 24320048
EMBO J. 2019 Jun 3;38(11):
pubmed: 31053596
Nat Struct Mol Biol. 2019 Mar;26(3):237-247
pubmed: 30833789
Trends Genet. 2015 May;31(5):239-51
pubmed: 25869999
Hepatology. 2012 Nov;56(5):1817-27
pubmed: 22689435
Cancer Res. 2015 Jun 1;75(11):2363-74
pubmed: 25855382
J Hematol Oncol. 2015 May 29;8(1):57
pubmed: 27391317
Anticancer Res. 2016 Dec;36(12):6389-6398
pubmed: 27919960
Gut. 2021 Jan;70(1):204-214
pubmed: 32747413
Cancer Biomark. 2018 Feb 14;21(3):651-659
pubmed: 29286922
Biochim Biophys Acta Mol Cell Res. 2021 Jan;1868(1):118837
pubmed: 32882261
Cell Rep. 2014 Sep 11;8(5):1365-79
pubmed: 25159147
Front Oncol. 2019 Nov 28;9:1292
pubmed: 31850199
J Biomed Sci. 2020 Mar 17;27(1):44
pubmed: 32183863
Nat Chem Biol. 2013 Jan;9(1):59-64
pubmed: 23160002
Mol Cell. 2019 Aug 8;75(3):523-537.e10
pubmed: 31256989
Mol Cell. 2015 Feb 5;57(3):552-8
pubmed: 25601759
Annu Rev Pharmacol Toxicol. 2017 Jan 6;57:81-105
pubmed: 27732800
Front Cell Infect Microbiol. 2017 May 26;7:205
pubmed: 28603696
Annu Rev Med. 2019 Jan 27;70:307-321
pubmed: 30691367
ACS Chem Biol. 2019 Feb 15;14(2):223-235
pubmed: 30620551
Hepatology. 2021 Feb;73(2):503-519
pubmed: 32314410
Cancer Res. 2017 Mar 1;77(5):1155-1167
pubmed: 27993818
Semin Liver Dis. 2013 May;33(2):147-56
pubmed: 23749671
BMC Genomics. 2017 Feb 17;18(1):184
pubmed: 28212627
Gut. 2020 Nov;69(11):2016-2024
pubmed: 32114505
Nat Rev Drug Discov. 2020 Oct;19(10):673-694
pubmed: 32782413
Mol Cell. 2019 Mar 7;73(5):869-883
pubmed: 30849394
Cancer Cell. 2014 Mar 17;25(3):335-49
pubmed: 24582836
Can J Gastroenterol Hepatol. 2018 Oct 15;2018:8410195
pubmed: 30410873
Cancers (Basel). 2020 May 16;12(5):
pubmed: 32429417
Cancers (Basel). 2021 May 28;13(11):
pubmed: 34071216
J Virol. 2010 Feb;84(4):2027-37
pubmed: 19939913
Cancer Sci. 2016 Feb;107(2):149-54
pubmed: 26614531
Biomedicines. 2021 May 14;9(5):
pubmed: 34068948
Science. 2010 Aug 6;329(5992):689-93
pubmed: 20616235
Open Biol. 2020 Sep;10(9):200126
pubmed: 32898472
Dis Markers. 2020 Jul 13;2020:5417598
pubmed: 32733618
Hepatology. 2012 Dec;56(6):2231-41
pubmed: 22706893
Mol Cell. 2010 Sep 24;39(6):925-38
pubmed: 20797886
Hepatology. 2018 Dec;68(6):2130-2144
pubmed: 29790592
Oncol Lett. 2018 Oct;16(4):4689-4698
pubmed: 30197680
Oncol Rep. 2020 Feb;43(2):718-726
pubmed: 31894346
Nucleic Acids Res. 2016 Jan 29;44(2):863-77
pubmed: 26578588
Hepatology. 2014 Oct;60(4):1278-90
pubmed: 25043274
J Cancer. 2018 Jun 23;9(15):2631-2639
pubmed: 30087703
Nat Med. 2016 Feb;22(2):128-34
pubmed: 26845405
Hepatoma Res. 2021;7:
pubmed: 33614973
Proc Natl Acad Sci U S A. 2011 Jan 11;108(2):786-91
pubmed: 21187392
Pharmacol Ther. 2016 May;161:67-78
pubmed: 27013343
Hepatology. 2016 Oct;64(4):1033-48
pubmed: 27338022
World J Gastroenterol. 2019 Sep 14;25(34):5026-5048
pubmed: 31558855
Cells. 2019 Sep 01;8(9):
pubmed: 31480503
J Hepatol. 2020 Feb;72(2):342-352
pubmed: 31954496
Genes Dev. 2014 Sep 15;28(18):1983-8
pubmed: 25170018
Transl Res. 2016 Feb;168:134-145
pubmed: 26551349
J Hepatol. 2010 Apr;52(4):594-604
pubmed: 20185200
Genomics. 2020 May;112(3):2583-2589
pubmed: 32068122
Mol Med Rep. 2018 Sep;18(3):3305-3313
pubmed: 30066898

Auteurs

Vincenzo Alfano (V)

Cancer Research Center of Lyon (CRCL), UMR Inserm 1052 CNRS 5286 Mixte CLB, Université de Lyon 1 (UCBL1), 69003 Lyon, France.

Mirjam B Zeisel (MB)

Cancer Research Center of Lyon (CRCL), UMR Inserm 1052 CNRS 5286 Mixte CLB, Université de Lyon 1 (UCBL1), 69003 Lyon, France.

Massimo Levrero (M)

Cancer Research Center of Lyon (CRCL), UMR Inserm 1052 CNRS 5286 Mixte CLB, Université de Lyon 1 (UCBL1), 69003 Lyon, France.
Hospices Civils de Lyon, Hôpital Croix Rousse, Service d'Hépato-Gastroentérologie, 69004 Lyon, France.
Department of Medicine SCIAC, University of Rome La Sapienza, 00161 Rome, Italy.

Francesca Guerrieri (F)

Cancer Research Center of Lyon (CRCL), UMR Inserm 1052 CNRS 5286 Mixte CLB, Université de Lyon 1 (UCBL1), 69003 Lyon, France.

Classifications MeSH